Influence of intrauterine injection of rat fetal hepatocytes on rejection of rat liver transplantation

World Journal of Gastroenterology

Volumn 9, Issue 1, 2003, Pages 137-140

  Yang, Yan Ling ^a   Dou, Ke Feng ^a   Li, Kai Zong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHILDBIRTH; CONTROLLED STUDY; CYTOTOXICITY TEST; EXPOSURE; FETUS; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; INJECTION; LIVER CELL; LIVER TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PREGNANCY; RAT; UTERUS;

EID: 0037439190     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i1.137     Document Type: Article

References (53)

1. Karim M, Steger U, Bushell AR, Wood KJ. The role of the graft in establishing tolerance. Front Biosci 2002; 7: 129-154
2. Riordan SM, Williams R. Transplantation of primary and reversibly immortalized human liver cells and other gene therapies in acute liver failure and decompensated chronic liver disease. World J Gastroenterol 2000; 6: 636-642
3. Tang ZY. Hepatocellular carcinoma - Cause, treatment and metastasis. World J Gastroenterol 2001; 7: 445-454
4. Zhu XF, Chen GH, He XS, Lu MQ, Wang GD, Cai CJ, Yang Y, Huang JF. Liver transplantation and artificial liver support in fulminant hepatic failure. World J Gastroenterol 2001; 7: 566-568
5. Platell CF, Coster J, McCauley RD, Hall JC. The management of patients with the short bowel syndrome. World J Gastroenterol 2002; 8: 13-20
6. Ouyang EC, Wu CH, Walton C, Promrat K, Wu GY. Transplantation of human hepatocytes into tolerized genetically immunocompetent rats. World J Gastroenterol 2001; 7: 324-330
7. Waldmann H, Cobbold S. Approaching tolerance in transplantation. Int Arch Allergy Immunol 2001; 126: 11-22
8. Yu X, Carpenter P, Anasetti C. Advances in transplantation tolerance. Lancet 2001; 357: 1959-1963
9. Qian YB, Cheng GH, Huang JF. Multivariate regression analysis on early mortality after orthotopic liver transplantation. World J Gastroenterol 2002; 8: 128-130
10. Shi LB, Peng SY, Meng XK, Peng CH, Liu YB, Chen XP, Ji ZL, Yang DT, Chen HR. Diagnosis and treatment of congenital choledochal cyst: 20 years' experience in China. World J Gastroenterol 2001; 7: 732-734
11. Bramhall S, Minford E, Gunson B, Buckels JA. Liver transplantation in the UK. World J Gastroenterol 2001; 7: 602-611
12. Womer KL, Lee RS, Marsden JC, Sayegh MH. Tolerance and chronic rejection. Philos Trans R Soc Lond B Biol Sci 2001; 356: 727-738
13. Zavazava N, Kabelitz D. Alloreactivity and apoptosis in graft rejection and transplantation tolerance. J Leukoc Biol 2000; 68: 167-174
14. Hong JC, Kahan BD. Immunosuppressive agents in organ transplantation: Past, present, and future. Semin Nephrol 2000; 20: 108-125
15. Bartlett A, McCall J, Munn S. Co-stimulatory blockade and tolerance induction in transplantation. BioDrugs 2001; 15: 491-500
16. Jones DR. In utero stem cell transplantation: Two steps forward but one step back? Expert Opin Biol Ther 2001; 1: 205-212
17. Hayashi S, Flake AW. In utero hematopoietic stem cell therapy. Yonsei Med J 2001; 42: 615-629
18. Flake AW. In utero transplantation of haemopoietic stem cells. Best Pract Res Clin Haematol 2001; 14: 671-683
19. Cowan MJ, Chou SH, Tarantal AF. Tolerance induction post in utero stem cell transplantation. Ernst Schering Res Found Workshop 2001; 33: 145-171
20. Kim HB, Shaaban AF, Milner R, Fichter C, Flake AW. In utero bone marrow transplantation induces donor-specific tolerance by a combination of clonal deletion and clonal anergy. J Pediatr Surg 1999; 34: 726-729
21. Rubin JP, Cober SR, Butler PE, Randolph MA, Gazelle GS, Ierino FL, Sachs DH, Lee WP. Injection of allogeneic bone marrow cells into the portal vein of swine in utero. J Surg Res 2001; 95: 188-194
22. Takahashi T, Kakita A, Sakamoto I, Takahashi Y, Hayashi K, Tadokoro F, Yamashina S. Immunohistochemical and electron microscopic study of extrinsic hepatic reinnervation following orthotopic liver transplantation in rats. Liver 2001; 21: 300-308
23. Boros P, Tarcsafalvi A, Wang L, Megyesi J, Liu J, Miller CM. Intrahepatic expression and release of vascular endothelial growth factor following orthotopic liver transplantation in the rat. Transplantation 2001; 72: 805-811
24. Okano S, Eto M, Tomita Y, Yoshizumi T, Yamada H, Minagawa R, Nomoto K, Sugimachi K, Nomoto K. Cyclophosphamide-induced tolerance in rat orthotopic liver transplantation. Transplantation 2001; 71: 447-456
25. He XS, Huang JF, Chen GH, Zheng KL, Ye XM. A successful case of combined liver and kidney transplantation for autosomal dominant polycystic liver and kidney disease. World J Gastroenterol 1999; 5: 79-80
26. Zhang SG, Wu MC, Tan JW, Chen H, Yang JM, Qian QJ. Expression of perforin and granzyme B mRNA in judgement of immunosuppressive effect in rat liver transplantation. World J Gastroenterol 1999; 5: 217-220
27. Genden EM, MacKinnon SE, Yu S, Hunter DA, Flye MW. Pre-treatment with portal venous ultraviolet B-irradiated donor alloantigen promotes donor-specific tolerance to rat nerve allografts. Laryngoscope 2001; 111: 439-447
28. Horimoto H, Nakai Y, Nakahara K, Nomura Y, Mieno S, Sasaki S. HMG-CoA reductase inhibitor cerivastatin prolonged rat cardiac allograft survival by blocking intercellular signals. J Heart Lung Transplant 2002; 21: 440-445
29. Hehmke B, Schroder D, Kloting I, Kohnert KD. Complement-dependent antibody-mediated cytotoxicity (CAMC) to pancreatic islet cells in the spontaneously diabetic BB/OK rat: Interference from cell-bound and soluble inhibitors. J Clin Lab Immunol 1991; 35: 71-81
30. Tange S, Scherer MN, Graeb C, Weiss T, Justl M, Frank E, Andrassy J, Jauch KW, Geissler EK. The antineoplastic drug paclitaxel has immunosuppressive properties that can effectively promote allograft survival in a rat heart transplant model. Transplantation 2002; 73: 216-223
31. Reyes J, Mazariegos GV, Bond GM, Green M, Dvorchik I, Kosmach-Park B, Abu-Elmagd K. Pediatric intestinal transplantation: Historical notes, principles and controversies. Pediatr Transplant 2002; 6: 193-207
32. Bassas AF, Chehab MS, Al-Shahed MS, Djurberg HG, Al-Shurafa HA, Jawdat MT, Al-Hussaini HF, Zuleika MA, Al-Hebby HA, Wali SH. Pediatric living-related liver transplantation in Saudi Arabia. Saudi Med J 2002; 23: 640-644
33. Robinson LG, Hilinski J, Graham F, Hymes L, Beck-Sague CM, Hsia J, Nesheim SR. Predictors of cytomegalovirus disease among pediatric transplant recipients within one year of renal transplantation. Pediatr Transplant 2002; 6: 111-118
34. Samsonov D, Briscoe DM. Long-term care of pediatric renal transplant patients: From bench to bedside. Curr Opin Pediatr 2002; 14: 205-210
35. Rela M, Dhawan A. Liver transplantation in children. Indian J Pediatr 2002; 69: 175-183
36. Fine RN. Growth following solid-organ transplantation. Pediatr Transplant 2002; 6: 47-52
37. Bucuvalas JC, Ryckman FC. Long-term outcome after liver transplantation in children. Pediatr Transplant 2002; 6: 30-36
38. Shneider BL. Pediatric liver transplantation in metabolic disease: Clinical decision making. Pediatr Transplant 2002; 6: 25-29
39. He XS, Huang JF, Chen GH, Fu Q, Zhu XF, Lu MQ, Wang GD, Guan XD. Orthotopic liver transplantation for fulminant hepatitis B. World J Gastroenterol 2000; 6: 398-399
40. Guan WX, Li KZ, Dou KF. Hepatocellular carcinoma and liver transplantation. Shijie Huaren Xiaohua Zazhi 2001; 9: 1292-1295
41. Song WL, Wang WZ, Wu GS, Dong GL, Ling R, Ji G, Zhao JX. Evaluation of perioperative serum cytokine level in acute rejection in human living-related small bowel transplantation. Shijie Huaren Xiaohua Zazhi 2001; 9: 401-404
42. He XS, Huang JF, Chen GH, Zheng KL, Ye XM. A successful case of combined liver and kidney transplantation for autosomal dominant polycystic liver and kidney disease. World J Gastroenterol 1999; 5: 79-80
43. Prevot A, Martini S, Guignard JP. Exposure in utero to immunosuppressives. Rev Med Suisse Romande 2001; 121: 283-291
44. Tanaka SA, Hiramatsu T, Oshitomi T, Imai Y, Koyanagi H. Induction of donor-specific tolerance to cardiac xenografts in utero. J Heart Lung Transplant 1998; 17: 888-891
45. Mackenzie TC, Shaaban AF, Radu A, Flake AW. Engraftment of bone marrow and fetal liver cells after in utero transplantation in MDX mice. J Pediatr Surg 2002; 37: 1058-1064
46. Taylor PA, McElmurry RT, Lees CJ, Harrison DE, Blazar BR. Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients. Blood 2002; 99: 1870-1872
47. Barker JE, Deveau S, Lessard M, Hamblen N, Vogler C, Levy B. In utero fetal liver cell transplantation without toxic irradiation alleviates lysosomal storage in mice with mucopolysaccharidosis type VII. Blood Cells Mol Dis 2001; 27: 861-873
48. Casal ML, Wolfe JH. In utero transplantation of fetal liver cells in the mucopolysaccharidosis type VII mouse results in low-level chimerism, but overexpression of beta-glucuronidase can delay onset of clinical signs. Blood 2001; 97: 1625-1634
49. Surbek DV, Holzgreve W, Nicolaides KH. Haematopoietic stem cell transplantation and gene therapy in the fetus: Ready for clinical use? Hum Reprod Update 2001; 7: 85-91
50. Surbek DV, Gratwohl A, Holzgreve W. In utero hematopoietic stem cell transfer: Current status and future strategies. Eur J Obstet Gynecol Reprod Biol 1999; 85: 109-115
51. Flake AW, Zanjani ED. In utero transplantation for thalassemia. Ann N Y Acad Sci 1998; 850: 300-311
52. Pschera H. Stem cell therapy in utero. J Perinat Med 2000; 28: 346-354
53. Stanworth SJ, Newland AC. Stem cells: Progress in research and edging towards the clinical setting. Clin Med 2001; 1: 378-382